DVAX - Dynavax saw some market movement today with some news hitting the market regarding hepatitis B vaccine. Recently the company has had 2 failed attempts with the FDA. The company is trying testing a third time around and investors are waiting for results. The FDA is set to release a verdict regarding the "Biological License Application" filing for the vaccine on November 10th. The stock sold off for around -5% today. There are some important levels on the charts in our opinion. If the stock rejects $20.64 we could see additional sell offs in our opinion. If it can bounce off $20.64 levels, we could see upward momentum to test the $22.38 levels in our opinion. MACD and RSI are still trending down, so we may very well see that $20.64 level rejected.
OPK - OPKO Health Inc missed analyst expectations and saw a sell off of -1.38% today. Analysts were projecting $319.4 million in revenues and the company reported revenues slipping to $263.5 million. The companies net loss came in at $0.08/share compared to a loss of $0.03/share a year ago. Solid support levels sit around $6.36. If the stock rejects these levels, we could see additional selling as there is a big potential gap down. It will be critical to see how the stock reacts to support at $6.36.
VRX - Valeant Pharma had a solid day today +5.53% on the day. Moodys changed their outlook on the company today from negative to stable which seemed to fuel some buying pressure today driving prices up. With the strong upward momentum today, it drove RSI to overbought territory today. With that being said we will be watching a couple prices level. If the stock can surpass $15.30 levels it could be signaling additional upward momentum in our opinion. On the other hand if the stock rejects $13.97 levels, we could see the RSI cooling off and forming a short term correction in our opinion.
Comments